Eisbruch A, Ship J A, Martel M K, Ten Haken R K, Marsh L H, Wolf G T, Esclamado R M, Bradford C R, Terrell J E, Gebarski S S, Lichter A S
Department of Radiation Oncology, University of Michigan, Ann Arbor, USA.
Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):469-80. doi: 10.1016/s0360-3016(96)00264-7.
To minimize xerostomia in patients receiving bilateral head and neck irradiation (RT) by using conformal RT planning to spare a significant volume of one parotid gland from radiation.
The study involved 15 patients with head and neck tumors in whom bilateral neck radiation was indicated. The major salivary glands and the targets (tumor, surgical bed, metastases to lymph nodes, and the locations of lymph nodes at risk for metastases) were outlined on axial computed tomography images. Beam's-eye view (BEV) displays were used to construct conformal beams that delivered the prescribed doses to the targets while sparing from direct radiation most of one parotid gland. The gland that was planned to be spared resided in the neck side that was judged in each patient to be at a lesser risk of metastatic disease. Major salivary gland flow rates and the responses to a subjective xerostomia questionnaire were assessed before, during, and after radiation.
Radiation planning for patients with central oropharyngeal tumors required the generation of multiple axial nonopposed beams. The resulting isodoses encompassed the targets, including the retropharyngeal nodes and the jugular nodes up to the base of skull bilaterally, while limiting the dose to the oral cavity, spinal cord, and one parotid gland. For patients with lateralized tumors, the ipsilateral neck side was treated up to the base of the skull; in the contralateral neck side, the treatment included the subdigastric nodes but excluded the jugular nodes at the base of the skull and most of the parotid gland. This was accomplished by a moderate gantry angle that was chosen using the BEV displays. Three months following the completion of radiation, the spared parotid glands retained on average 50% of their unstimulated and stimulated flows. In contrast, no saliva flow was measured from the unspared glands in any of the patients. Subjective xerostomia was absent, mild, or not different from that reported before radiation in 10 of 15 patients (67%).
Partial parotid gland sparing is feasible by using three-dimensional planning in patients undergoing bilateral head and neck radiation. Approximately 50% of the saliva flow from the spared glands may be retained, and most patients thus treated have no or mild xerostomia in the early period after the completion of radiation. Whether tumor control and late complications are comparable to standard radiation will be assessed as more experience is gained.
通过使用适形放疗计划使一侧腮腺的大部分体积免受辐射,从而将接受双侧头颈部放疗(RT)患者的口干症降至最低。
该研究纳入了15例有双侧颈部放疗指征的头颈部肿瘤患者。在轴向计算机断层扫描图像上勾勒出主要唾液腺和靶区(肿瘤、手术床、淋巴结转移灶以及有转移风险的淋巴结位置)。利用射野方向观(BEV)显示来构建适形射束,将规定剂量的射线传递至靶区,同时使一侧腮腺的大部分免受直接辐射。计划保留的腮腺位于每位患者判断为转移疾病风险较低的颈部一侧。在放疗前、放疗期间和放疗后评估主要唾液腺的流速以及对主观口干问卷的反应。
对于中央型口咽肿瘤患者,放疗计划需要生成多个轴向非对穿射束。由此产生的等剂量线涵盖了靶区,包括双侧咽后淋巴结和直至颅底的颈静脉淋巴结,同时将口腔、脊髓和一侧腮腺的剂量限制在一定范围内。对于偏侧肿瘤患者,同侧颈部直至颅底接受治疗;在对侧颈部,治疗包括二腹肌下淋巴结,但不包括颅底的颈静脉淋巴结和大部分腮腺。这是通过使用BEV显示选择合适的机架角度来实现的。放疗结束三个月后,保留的腮腺平均保留了其非刺激和刺激流速的50%。相比之下,所有患者中未保留的腮腺均未测到唾液流速。15例患者中有10例(67%)无主观口干、口干轻微或与放疗前报告的情况无差异。
对于接受双侧头颈部放疗的患者,通过三维计划保留部分腮腺是可行的。保留的腮腺大约可保留50%的唾液流速,大多数接受此类治疗的患者在放疗结束后的早期无口干或仅有轻微口干。随着经验的积累,将评估肿瘤控制情况和晚期并发症是否与标准放疗相当。